Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trial (Q48518271)
Jump to navigation
Jump to search
scientific article published on 10 January 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trial |
scientific article published on 10 January 2018 |
Statements
1 reference
Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trial (English)
1 reference
Pierre Fenaux
1 reference
Gautam Borthakur
1 reference
Guillermo Garcia-Manero
1 reference
Michael R Savona
1 reference
Rami Komrokji
1 reference
David P Steensma
1 reference
Alan F List
1 reference
Jesus Berdeja
1 reference
Amy E DeZern
1 reference
Mikkael A Sekeres
1 reference
Lionel Ades
1 reference
Thomas Prebet
1 reference
Joseph G Jurcic
1 reference
Odile Beyne-Rauzy
1 reference
Aspasia Stamatoullas
1 reference
Jacques Delaunay
1 reference
Jennie Zhang
1 reference
Robert Rifkin
1 reference
Thomas E Boyd
1 reference
Abderrhamane Laadem
1 reference
Bond Vo
1 reference
Marie Puccio-Pick
1 reference
Kenneth M Attie
1 reference
10 January 2018
1 reference
5
1 reference
2
1 reference
e63-e72
1 reference